Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» OSI Pharmaceuticals
OSI Pharmaceuticals
OSI, Millipore takeover bids stoke biotech stocks
Marketwatch
Mon, 03/1/10 - 11:00 am
OSI Pharmaceuticals
Millipore
Astellas
drug stocks
M&A
Merck KGaA
Japan's Astellas bids $3.5 billion for OSI Pharma
Reuters
Mon, 03/1/10 - 10:48 am
OSI Pharmaceuticals
Astellas
M&A
The Future of Biotech: Party Like It's 1999
Seeking Alpha
Mon, 01/18/10 - 12:40 pm
Amgen
Genzyme
Biogen Idec
Celgene
Gilead Sciences
Teva Pharmaceuticals
Watson Pharmaceuticals
OSI Pharmaceuticals
Sunesis
Amag Pharmaceuticals
Jazz Pharmaceuticals
Indenix
Inspire
Novavax
Cyclacel
Cardica
Micromet
Rosetta Genomics
FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Sat, 01/16/10 - 11:08 am
Tarceva
OSI Pharmaceuticals
Genentech
Roche
OSI Pharmaceuticals trims 2010 revenue outlook
Yahoo/AP
Tue, 12/22/09 - 09:36 am
OSI Pharmaceuticals
earnings
outlook
Lilly to Benefit from OSI Rejection
Seeking Alpha
Thu, 12/17/09 - 04:00 pm
Eli Lilly
OSI Pharmaceuticals
Tarceva
lung cancer
Alimta
Panel Rejects Early Use of Tarceva
WSJ Online
Thu, 12/17/09 - 08:56 am
Tarceva
OSI Pharmaceuticals
FDA
lung cancer
Roche
Genentech
FDA says OSI drug effective against lung cancer
Yahoo/AP
Mon, 12/14/09 - 11:58 am
OSI Pharmaceuticals
lung cancer
FDA
Tarceva
Biotech Calendar: Key Dates for December
TheStreet.com
Mon, 11/30/09 - 11:02 am
Exelixis
Dyax
OSI Pharmaceuticals
Isis Pharmaceuticals
Somaxon
Gilead Sciences
Eli Lilly
Vion Pharmaceuticals
Roche
Immunogen
Auxilium
BioDelivery Sciences
Arena Pharmaceuticals
Vivus
Synta
Enzon Beats, Announces Sell-off
Yahoo/Zacks.com
Tue, 11/10/09 - 07:24 pm
Enzon
earnings
Merck
OSI Pharmaceuticals
Simcere to Develop OSI Pharmaceutical Cancer Drug in China
Seeking Alpha
Wed, 10/21/09 - 10:12 am
China
Simcere
OSI Pharmaceuticals
cancer
New Diabetes Drug Could Give Januvia Stiff Competition
Seeking Alpha
Tue, 08/4/09 - 07:50 am
Merck
diabetes
Januvia
Bristol-Myers Squibb
AstraZeneca
Takeda
Forest Labs
OSI Pharmaceuticals
Novartis
Onglyza
OSI expands cancer drug development partnership
Yahoo/AP
Tue, 07/21/09 - 05:15 pm
OSI Pharmaceuticals
partnerships
cancer
Aveo Pharmaceutical
OSIP gets boost from Tarceva tests
NASDAQ.com
Mon, 07/13/09 - 09:48 am
OSI Pharmaceuticals
Tarceva
lung cancer
Roche
Genentech
OSI Pharma drops as analyst lowers rating based on Tarceva lung cancer trial results
Yahoo/AP
Mon, 06/1/09 - 10:07 pm
OSI Pharmaceuticals
Tarceva
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Seeking Alpha
Wed, 05/27/09 - 07:41 am
Gilead Sciences
Amgen
Human Genome Sciences
Acorda Therapeutics
Biomarin
Amag Pharmaceuticals
Biogen Idec
Genzyme
Cougar Biotechnology
JNJ
OSI Pharmaceuticals
Cephalon
Allergan
Celgene
Myriad
Sequenom
Auxilium
OSI says Tarceva met goals in lung cancer trial
Yahoo/AP
Fri, 05/15/09 - 08:06 am
OSI Pharmaceuticals
Tarceva
drug trials
lung cancer
Biotech Rocket Stocks for the Week
TheStreet.com
Mon, 05/11/09 - 02:16 pm
biotech
Biocryst
Novavax
Pfizer
JNJ
Vanda
Cell Therapeutics
OSI Pharmaceuticals
OSI Pharma sues Teva and Mylan over Tarceva patent
Yahoo/AP
Fri, 03/20/09 - 11:52 am
OSI Pharmaceuticals
lawsuits
Teva Pharmaceuticals
Mylan
patents
Tarceva
generics
cancer
OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Yahoo
Thu, 03/19/09 - 06:45 am
OSI Pharmaceuticals
Tarceva
NDA
FDA
lung cancer
Pages
« first
‹ previous
1
2
3
4
next ›
last »